Context Therapeutics Inc. · NASDAQ:CNTX
Mpm Bioimpact LLC's stake in Context Therapeutics Inc. fell to 1.40% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Mpm Bioimpact LLC's stake in Context Therapeutics Inc. fell to 1.40%, 1,299,046 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 1.40%
- Shares
- 1,299,046
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| MPM BioImpact LLC | 1.40% | 1,299,046 |
Source
Related
- Context Therapeutics Inc.
- Mpm Bioimpact LLC
- Context Therapeutics Inc. shareholders
- Schedule 13G/A · Mpm Bioimpact LLC · Feb 17, 2026
- Schedule 13G · Mpm Bioimpact LLC · Jan 8, 2025
- Schedule 13G/A · Blue Owl Capital Holdings LP · Aug 12, 2026
- Schedule 13G/A · Octagon Capital Advisors LP · Jul 31, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Great Point Partners LLC · May 15, 2026
- Schedule 13G · Octagon Capital Advisors LP · May 14, 2026